Results
|
|
11881.
|
|
|
|
11882.
|
|
|
|
11883.
|
|
|
|
11884.
|
|
|
|
11885.
|
|
|
|
11886.
|
Phase I clinical trial of the farnesyltransferase inhibitor BMS-214662 administered as a weekly 24 h continuous intravenous infusion in patients with advanced solid tumors. [electronic resource] by
- Eder, Joseph P
- Ryan, David P
- Appleman, Leonard
- Zhu, Andrew X
- Puchalski, Thomas
- He, Xiaoying
- Sonnichsen, Daryl S
- Cooper, Michael
- Wright, John
- Clark, Jeffrey W
- Supko, Jeffrey G
Producer: 20060705
In:
Cancer chemotherapy and pharmacology vol. 58
Availability: No items available.
|
|
|
11887.
|
|
|
|
11888.
|
|
|
|
11889.
|
|
|
|
11890.
|
|
|
|
11891.
|
|
|
|
11892.
|
|
|
|
11893.
|
|
|
|
11894.
|
|
|
|
11895.
|
|
|
|
11896.
|
|
|
|
11897.
|
|
|
|
11898.
|
|
|
|
11899.
|
|
|
|
11900.
|
|